文献速递角膜与眼表疾病

SIRT1可保护人角膜与结膜上皮细胞免受颗粒物诱导的氧化应激损伤

SIRT1 Protects Against Particulate Matter-Induced Oxidative Stress in Human Corneal and Conjunctival Epithelial Cells.
PubMed 文献 · Invest Ophthalmol Vis Sci · 2022-01-01

本研究将永生化人角膜上皮细胞(HCECs)与人结膜上皮细胞(HCjECs)暴露于环境颗粒物(PM)样本,检测SIRT1表达及氧化应激相关损伤。结果显示PM以剂量依赖方式引起细胞毒性,200 µg/mL PM暴露后活性氧(ROS)升高、SIRT1表达下降,并出现凋亡、线粒体损伤与细胞衰老;SIRT1激活剂SRT1720可上调SIRT1、减少ROS并减轻上述损伤。

要点

  • PM对HCECs和HCjECs的细胞毒性呈剂量依赖性。
  • 200 µg/mL PM暴露后HCECs和HCjECs中ROS升高、SIRT1表达下降。
  • SIRT1激活剂SRT1720可上调SIRT1、减少ROS并减轻PM诱导的细胞损伤。

核心结论

  • SIRT1参与PM诱导的HCECs和HCjECs氧化应激,ROS过度产生可能是PM诱导SIRT1下调的关键因素。
  • SIRT1激活剂SRT1720能有效上调SIRT1表达并抑制ROS产生,从而逆转PM诱导的细胞损伤。
  • 该研究为PM相关眼表疾病的临床治疗提供了新的潜在靶点。

研究设计与样本

  • 体外研究,使用永生化人角膜上皮细胞(HCECs)和人结膜上皮细胞(HCjECs)暴露于环境PM样本。
  • 细胞毒性用水溶性四唑盐-8法评估,SIRT1表达用蛋白质印迹分析检测。
  • ROS产生、细胞凋亡、线粒体功能和细胞衰老分别用2',7'-二氯荧光素二乙酸酯法、膜联蛋白V凋亡检测、四甲基罗丹明乙酯法和衰老β-半乳糖苷酶染色评估。

主要发现

  • PM诱导的HCECs和HCjECs细胞毒性呈剂量依赖性。
  • HCECs和HCjECs在200 µg/mL PM暴露后ROS产生增加、SIRT1表达下降。
  • PM诱导氧化应激介导的细胞损伤,包括细胞凋亡、线粒体损伤和细胞衰老。
  • SIRT1激活剂SRT1720使HCECs和HCjECs中SIRT1表达增加、ROS产生减少,并减轻PM诱导的细胞损伤。

临床怎么用

  • 原文结论提出SIRT1激活剂SRT1720可有效上调SIRT1表达并抑制ROS产生,从而逆转PM诱导的细胞损伤,为PM相关眼表疾病的临床治疗提供了新的潜在靶点。
  • 原文未据此给出具体临床推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: Sirtuin1 (SIRT1) as a hot therapeutic target for oxidative stress-associated diseases that has been extensively studied. This study aimed to determine the changes in SIRT1 expression in particulate matter (PM)-induced corneal and conjunctival epithelial cell damage and explore potential drugs to reduce PM-associated ocular surface injury. METHODS: Immortalized human corneal epithelial cells (HCECs) and human conjunctival epithelial cells (HCjECs) were exposed to an ambient PM sample. Cytotoxicity was evaluated by water-soluble tetrazolium salt-8 assay. SIRT1 expression was measured by Western blot analysis. Reactive oxygen species (ROS) production, cell apoptosis, mitochondrial function, and cell senescence were assessed by using 2',7'-dichlorofluorescein diacetate assay, annexin V apoptosis assay, tetramethylrhodamine ethyl ester assay, and senescence β-galactosidase staining, respectively. RESULTS: PM-induced cytotoxicity of HCECs and HCjECs occurred in a dose-dependent manner. Increased ROS production, as well as decreased SIRT1 expression, were observed in HCECs and HCjECs after 200 µg/mL PM exposure. In addition, PM induced oxidative stress-mediated cellular damage, including cell apoptosis, mitochondrial damage, and cell senescence. Interestingly, SRT1720, a SIRT1 activator, increased SIRT1 expression and decreased ROS production and attenuated PM-induced cell damage in HCECs and HCjECs. CONCLUSIONS: This study determined that SIRT1 was involved in PM-induced oxidative stress in HCECs and HCjECs and found that ROS overproduction may a key factor in PM-induced SIRT1 downregulation. The SIRT1 activator, SRT1720, can effectively upregulate SIRT1 expression and inhibit ROS production, thereby reversing PM-induced cell damage. This study provides a new potential target for clinical treatment of PM-associated ocular surface diseases.

来源:Invest Ophthalmol Vis Sci,查看原文。版权归原作者所有。

引用

  1. Li X, Kang B, Eom Y, et al. SIRT1 Protects Against Particulate Matter-Induced Oxidative Stress in Human Corneal and Conjunctival Epithelial Cells. Invest Ophthalmol Vis Sci. 2022. PMID: 36169947. doi:10.1167/iovs.63.10.19

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。